Details of the Drug

General Information of Drug (ID: DM1PXAU)

Drug Name

GS-5894

Synonyms

2,4-Dichloro-5-iodopyrimidine; 13544-44-0; 2, 4-dichloro-5-iodopyrimidine; 5-iodo-2,4-dichloropyrimidine; MFCD01898087; 2,4-Dichloro-5-iodo-pyrimidine; NSC97872; NCIOpen2_006533; 2,4-Chloro-5-iodopyrimidine; SCHEMBL117265; 5-iodo-2, 4-dichloropyrimidine; DTXSID90294754; RGJNPJRAXMSHKN-UHFFFAOYSA-N; BCP22998; NSC 97872; NSC-97872; AKOS002665245; 2,4-Dichloro-5-iodopyrimidine, 95%; AB10498; AC-1289; CS-W002862; GS-5894; SY009554; AM20080261; D4122; FT-0602319; EN300-252921; W-201138; Z1269214376

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus-1 infection	1C62	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C4HCl2IN2
Canonical SMILES: C1=C(C(=NC(=N1)Cl)Cl)I
InChI: InChI=1S/C4HCl2IN2/c5-3-2(7)1-8-4(6)9-3/h1H
InChIKey: RGJNPJRAXMSHKN-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 263438
TTD ID: DKW80C

References

1	ClinicalTrials.gov (NCT05585307) An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretrovirals in Participants With HIV-1. U.S.National Institutes of Health.